Transglutaminase and polyamine dependence of effector functions of human immunocompetent cells The effect of specific inhibitors on lymphocyte proliferation and granulocyte chemiluminescence by Günzler, Volkmar et al.
Volume 150, number 2 FEBS LETTERS December 1982 
Transglutaminase and polyamine dependence of effector 
functions of human immunocompetent cells 
The effect of specific inhibitors on lymphocyte proliferation 
and granulocyte chemiluminescence 
Volkmar Giinzler, Rudolf E. Schopf+, Hartmut M. Hanauske-Abel 
and Hermann Schulte-Wissermann 
Kinderklinik und +Hautklinik der Johannes-Gutenberg Universittit, Labor 40, NSK-Gebiiude, Langenbeckstr., 
D-6500 Mainz, FRG 
Received 3 September 1982; revision received 3 November 1982 
The effects of the transglutaminase inhibitor dansyl cadaverine (DC) and the polyamine antagonist methyl 
glyoxal-bis-(guanylhydrazone) (MeGbG) on the response of lymphocytes towards allogeneic and lectin 
stimulation and on the zymosan-induced chemiluminescence of neutrophilic granulocytes was studied. 
Application of DC resulted in dose-dependent suppression of chemiluminiscence and lymphocyte 
proliferation; no difference of inhibitory potential occurred with variation of incubation time in the latter 
system. MeGbG was inactive in granulocytes, but inhibited lymphocyte proliferation; its effect increased 
with time. The experiments provide further evidence for the importance of transglutaminases and 
polyamines for the function of immunocompetent cells. 
Transglutaminase Polyamine Dansyl cadaverine MeGbG Lymphocyte Granulocyte 
Abbreviations: C, concentration of inhibitors; Ioj’,, per 
cent inhibition, calculated as: 
1% = 100 
_ 
( 
loo x2ctivity of inhibited sample - background 
activity of uninhibited sample - background ) 
ID~o, concentration of inhibitor yielding 50% inhibition; 
LDH, lactate dehydrogenase; MNC, mononuclear leuco- 
cytes (lymphocytes and macrophages) 
t This paper is dedicated to Professor Gerd Brunner. He 
postulated that cellular functions (e.g., gene ex- 
pression) depend on membrane-located information 
transduction systems activated by external signals, a 
process for which he coined the term ‘membrane im- 
pression’ [l]. Gerd and his companion, Dr Wolf, both 
excellent alpinists, did not return from an ascent o the 
Gasherbrum II peak (8036 m), Northern Pakistan, in 
early July, 1982 
1. INTRODUCTION 
Transglutaminases (TGases), comprising a whole 
family of enzymes with different specificity and 
functions [2], catalyze the formation of amido 
bonds, involving the 5-carbamyl moiety of peptidyl 
glutamine, and an amine (fig. 1). The best- 
characterized member of this family is blood 
coagulation factor XIII. TGases are capable of 
crosslinking proteins on the cell surface [3,4] and 
in solution [4,5]. TGases are essential for the in- 
ternalization of specifically bound ligands (recep- 
tor-mediated endocytosis) at least in fibroblasts, 
kidney and tumor cells [6-lo]. 
Evidence has arisen that membrane-associated 
TGase activity is also related to receptor-mediated 
functions of immunocompetent cells. It sharply 
rises after lectin stimulation of mononuclear leuco- 
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0yNH2 -= 
Fig. 1. Schematic representation of TGase-catalyzed 
reactions: R and R’, peptidyl backbone of the gluta- 
minyl susstrate; R”, residue of peptidyl lysine, poly- 
amines or synthetic amine substrates (e.g., dansyl 
cadaverine). 
cyte (MNC) cultures [ 111, which results in lympho- 
cyte proliferation. TGase activity is also enhanced 
by immune complex binding to phagocytes [I2], 
which results in an increased oxygen uptake and 
the production of cytotoxic hydroxyl radicals, 
singlet oxygen, per- and superoxides [13]. This 
respiratory burst is induced by appropriate stimu- 
lants [14,15]. Whether the relation of TGase 
activity to these processes is causal or coinciden- 
tial, i.e., whether immune functions can be sup- 
pressed by direct TGase inhibition, has not yet 
been clarified. 
The model compound for TGase inhibition is 
dansyl cadaverine (DC). It directly competes for 
the amine binding site [7,8,10] and is covalently 
incorporated into proteins by TGase action [3,16]. 
DC inhibits the receptor-mediated endocytosis of 
insulin, az-macroglobulin, polypeptide hormones 
and virus in various cells [6-8,101. 
One of the functions of TGases is the incorpora- 
tion of physiological polyamines into proteins 
[2,17]. This post-translational modification can 
yield both crosslinked and non-crosslinked pro- 
ducts [2,17,18]; i.e., polyamines are used for side- 
chain modifications resulting in unusual amino 
acids [18] or for the formation of intermolecular 
bridges [2,17]. Aside from being TGase substrates, 
polyamines are of vital importance in differentia- 
tion, proliferation, and gene expression [ 19-221. 
Thus the polyamine and TGase systems appear to 
be interlocked, but not identical; interference with 
polyamine metabolism and inhibition of TGase 
activity should lead to differing results. 
The model compound for polyamine antimeta- 
bolites is methyl glyoxal-bis-(guanylhydrazone) 
(MeGbG). It interferes with synthesis and trans- 
port of spermidine [21] and, consequently, sper- 
mine. MeGbG has been used as an antileucemic 
agent not only experimentally, but also clinically 
[23,24]; it is known to suppress polyamine-depen- 
dent [25] lymphocyte proliferation [21,23]. Because 
of the existence of an intracellular pool of poly- 
amines [26], it should be expected that the maximal 
inhibitory effect of MeGbG will be reached only 
after depletion of this pool. Thus far, no kinetic 
data have been available. 
The inhibitory potential of both compounds was 
tested in the concanavalin A (con-A)-induced as 
well as allogeneic stimulation of lymphocyte pro- 
liferation, measured as incorporation of [3H]thy- 
midine, and in the zymosan-induced respiratory 
burst of polymorphonuclear leucocytes (PMN), 
measured as chemiluminescence [27]. 
2. MATERIALS AND METHODS 
2.1. Separation of cells 
Heparinized blood from healthy donors was cen- 
trifuged on an equal volume of sterilized Ficoll for 
30 min at 1800 rev./min. The interphase mono- 
nuclear leucocytes (MNC) were collected, washed 
3 times with RPM1 1640 medium (Boehringer, 
Ingelheim) and adjusted to 2 x lo6 cells/ml. The 
pellet of the centrifugation, containing erythro- 
cytes and PMN cells, was allowed to settle in a 1% 
dextran solution for 45 min at 1 x g. Pure PMN 
suspensions were gained from the resulting super- 
natant by lysis of residual erythrocytes with 0.98% 
NH4C1 solution, in order to prevent quenching of 
chemiluminescence. 
2.2. Procedure of stimulation 
The allogeneic and lectin-induced stimulation 
experiments of MNC cultures were carried out in 
microtiter plates (Titertek). Only the central 32 
wells of each plate were used, the remaining ones 
filled with medium. 
In con A stimulations, 50 ~1 cell suspension 
(lo5 cells) were added to 50 ~1 con A solution 
(lOO,~g/ml, Paesel, Frankfurt), 100,ul 25% heat- 
inactivated AB serum, and 50 ~1 inhibitor solu- 
tions; 50~1 pure medium was substituted for 
con A in unstimulated and, for inhibitor solution, 
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uninhibited controls. The cultures were incubated and 0.5 PM - 0.133 mM in the chemiluminescence 
at 37°C in a humidified atmosphere of 5% COZ, assay. These ranges had been determined to cover 
using RPM1 1640 medium supplemented with both zero and 100% inhibition in preliminary ex- 
10’ U/l penicillin/streptomycin. Medium (50 pl) periments. Because DC was not readily soluble in 
containing 1 &i [3H]thymidine was added at 24, medium, it was dissolved in 100 pl/mg 70% 
48 or 72 h. After an additional 24 h incubation, ethanol and diluted appropriately with medium. 
cells were harvested on Tritertek fiberglass filters Controls showed that the resulting concentrations 
and washed 10 times with 0.9% NaCl. The filters of alcohol had no effect in MNC cultures; in the 
were then dried, placed in small liquid scintillation chemiluminescence assay, ethanol at ~0.1% re- 
tubes, covered with 1 ml Insta-fluor liquid scin- duced photon emission. The inhibition values were 
tillation cocktail (Packard) and radioactivity was corrected accordingly. MeGbG (EGA, Steinheim) 
determined with a Kontron MR-300 counter, using was used at l-60 PM in con A cultures as well as 
the 3H fix-window with automatic dpm calcula- in zymosan experiments, and 62.5 nM-30pM in 
tion. MLC. 
In mixed lymphocyte cultures (MLC) peripheral 
blood cells of two healthy donors were used for 
responder/stimulator combinations. Responder 
cell suspension (50 ~1, 2 x 106/ml) were added to 
50 ~1 stimulator cells (2 x 106/ml, irradiated with 
2500 rad), 50 ~180% heat-activated AB serum, and 
50 ,ul inhibitor solution (pure medium for un- 
inhibited controls). Autostimulation was excluded 
by combining responder and stimulator cells of the 
same donor. [3H]Thymidine was added after 
120 h. The further procedure paralleled the con A 
experiments. 
2.5. Control experiments 
In the lymphocyte experiments, separate plates 
were prepared to test the viability of the cells by 
intra- and extracellular determination of LDH acti- 
vity, as well as using the eosin dye exclusion test to 
In the chemiluminescence assay, 100~1 PMN 
cell suspension (5 x lo5 cells) were incubated for 
10 min in 12 x 47 mm polystyrol cuvettes (Lumac, 
Dusseldorf) at 37°C in a water bath. Then 100,ul 
freshly prepared Luminol (Fluka, Buchs) at final 
cont. 2 x 10e4 M, 50 ~1 zymosan suspension (final 
cont. 0.33 mg/ml) or pure medium for unstimu- 
lated controls and 50 ,ul inhibitor solution (pure 
medium for uninhibited controls) were added. The 
mixture was kept at 37°C and chemiluminescence 
was measured in duplicate samples at 15, 30 and 
45 min in a Biolumat LB 9500 analyzer (Berthold, 
Wildbad). 
I T I 
loglOCI /M 
2.3. Preparation of zymosan suspensions 
Zymosan particles were suspended in physiologi- 
cal saline, heated in a boiling water bath for 
20 min, washed twice, resuspended at 2 mg/ml 
with MEM and kept frozen in small aliquots at 
-20°C until use. 
2.4. Inhibitors 
DC (Fluka, Buchs) was used at final cont. 
10 /M-0.16 mM in both types of MNC cultures, 
Fig. 2. Dose-dependent i hibition of [3H]thymidine 
incorporation in lymphocyte cultures by dansyl cada- 
verine. Bars indicate standard eviation of 4 samples, in
uninhibited controls (u.c.) of 8 samples. Statistical 
significance on the 1% level @ < 0.01) required at least 
30% inhibition, compared to uninhibited controls. Un- 
stimulated controls accumulated <500 dpm: (0) con A 
stimulation, 48 h incubation; (0) con A stimulation, 
96 h incubation; (A) mixed lymphocyte cultures, 144 h 
incubation. The 72 h incubation period has not been 
included. 
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prove no cytotoxic activity of the inhibitors after 
72 h of incubation. Immediately before harvesting, 
cluster formation of the cultures was evaluated 
microscopically. Viability of PMN was controlled 
by dye exclusion. 
3. RESULTS 
Direct inhibition of TGase activity by DC re- 
sulted in dose-dependent suppression of 3H-incor- 
poration in both types of lymphocyte cultures (fig. 
2). Inhibition was uniformly characterized by an 
IDSO of 70 ,uM. In the chemiluminescence assay, 
dose-dependent inhibition was also obtained; IDSO, 
however, was only 6 PM (fig. 3). DC reduced the 
viability of lymphocytes slightly, but insignifi- 
cantly at >40 PM (SO’J7o living cells at 160 PM and 
94% at 80pM, compared to 97(rlo in controls), as 
shown by the eosin dye-exclusion test. The total 
number of cells did not decrease during incubation 
with DC even at the highest concentration. LDH in 
culture medium was not significantly elevated. In 
the PMN stimulation experiments, viability of cells 
exceeded 98%. 
MeGbG was not active as an inhibitor of chemi- 








-6 -5 ,0&M 
Fig. 3. The effect of dansyl cadaverine in the zymosan- 
induced chemiluminescence of polymorphonuclear 
leucocytes (0). Each point represents the mean of dupli- 
cate measurements at the maximum of activity (30 min 
incubation); the values were corrected for background 
and for the effect of alcohol (section 2). Unstimulated 
controls yielded 9.5 x lo3 counts/l0 s, uninhibited con- 
trols 2.9 x lo5 counts/l0 s. Methyl glyoxal-bis-(guanyl- 
hydrazone) (A) was not active as an inhibitor at 960 ,uM. 
cyte experiments, MeGbG application resulted in 
dose-dependent suppression of tritium accumula- 
tion (fig. 4). In contrast to inhibition by DC, the 
effect of MeGbG strikingly increased with the 
duration of incubation: ZDSO dropped from 15 PM 
after 48 h to 0.25 PM after 144 h (fig. 5). MeGbG 
did not diminish total number or viability of cells 
- 
-7 -6 -5 
Fig. 4. Dose-dependent inhibition of [3H]thymidine 
incorporation in lymphocyte cultures by methyl glyoxal- 
bis-(guanylhydrazone). Conditions and symbols identical 








i 3 L 6 
lncubotlon Idoysl 
Fig. 5. Time-dependent increase of the inhibitory poten- 
tial of MeGbG at various concentrations. From top to 
bottom: 30, 15, 7.5, 3.75 and 1 ,uM. The values have 
been compiled from con A (days 2-4) and mixed 
lymphocyte experiments (day 6). 
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IDso Total inhibition 
(PM) (/JM)~ 
Effects of DC 
Zymosan-induced stimulation of PMN 0.75 2 
Con A stimulation of MNC 48 40 
72 40 
96 40 
Mixed lymphocyte culture 144 40 
Effects of MeGbG 
Zymosan-induced stimulation of PMN 0.75 >60 
Con A stimulation of MNC 48 4 
72 2 
96 <l 
Mixed lymphocyte culture 144 0.1 
a Minimal concentration of inhibitor yielding at least 10% inhibition 











in the eosin dye-exclusion test, nor did it elevate 
medium LDH levels in any concentration used. 
Cluster formation was inhibited by neither sub- 
stance in concentrations completely suppressing 
thymidine incorporation in the lymphocyte cul- 
tures. The results of all experiments are sum- 
marized in table 1. 
4. DISCUSSION 
The inhibition of effector functions of immuno- 
competent cells by DC demonstrates their TGase 
dependence. 
The inhibition of internalization of externally 
bound macromolecules by DC in fibroblasts [7,8] 
have led to the postulation [lo] of TGase participa- 
tion in receptor-mediated endocytosis. TGase, acti- 
vated as a consequence of ligand binding to mem- 
brane receptors, was suggested to concentrate and 
trap ligand-receptor complexes in specialized 
membrane areas called ‘coated pits’ as a pre- 
requisite of their internalization as ‘receptosomes’. 
This process characteristically takes place within 
minutes, and does not necessarily require de novo 
synthesis of cell structures [28]. The respiratory 
burst in phagocytes resembles endocytosis in 
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several aspects: it is mediated by receptors, it takes 
place within minutes, it is TGase-dependent, and it 
does not necessarily require de novo synthesis of 
cell structures. Obviously, the specific effect of 
these similar processes depends on the cell type. 
On the other hand, while lymphocyte prolifera- 
tion is also mediated by membrane receptors and 
dependent on TGase activity, there are striking dif- 
ferences to fibroblast and granulocyte activation: 
proliferation requires de novo synthesis of cell 
structures, and takes place in hours, not minutes. 
Apparently, TGases fulfill the requirements of 
an information transduction system: a uniform in- 
itiation step (receptor-mediated enzyme activation) 
is able to produce entirely different effects in dif- 
ferent cells. The existence and the universal impor- 
tance of such transduction systems was postulated 
by Gerd Brunner: 
’ . . . the cell membrane, by transduction of signals 
from the outside, acts as a central regulatory point 
and posesses an equivalent counterpart function to 
the genome’ [II 
The comparison of ICso values of DC inhibition of 
these processes (300 PM in fibroblasts [8], 70 PM 
in mononuclear cells and 6 PM in granulocytes) 
indicates that specificity is achieved by substrate- 
Volume 150, number 2 FEBS LETTERS December 1982 
specific susceptibility, most plausibly explained by 
the existence of isoenzymes. 
The time-dependence of MeGbG inhibition in 
the lymphocyte experiments and its inactivity in the 
PMN test demonstrate the incongruency of TGase 
and polyamine systems with respect to recep- 
tor-mediated activation. The kinetics indicate that 
turnover and depletion of the pre-existing pool of 
polyamines proceed slowly. Half-lives of 12-42 
days were reported [26], but are not comparable as 
turnover in organs, not in cell culture, were stu- 
died; we were not able to sustain lymphocyte 
cultures long enough to reach a plateau in the time- 
course of MeGbG inhibition, indicating that even 
after 6 days, the polyamine pool is not totally 
depleted. The consequences of these results have 
been anticipated by the empirical finding that 
weekly, rather than daily, application of an overall 
dose reduced by 30% enhances the therapeutic 
index of the drug [24]. 
We cannot yet decide whether phagocyte chemi- 
luminescence involves the utilization of polyamines. 
This process may be completely independent of the 
polyamine system, or the depletion of the pool may 
be negligible, due to the short duration of the 
respiratory burst. However, even if chemilumin- 
escence is not independent of the presence of poly- 
amines, it is certainly independent of their synthesis 
and transport. This circumstance, which disen- 
tangles the connection of TGase and polyamine 
systems, the rapidity and simplicity of procedure, 
and the quantitative nature of the results, make 
phagocyte chemiluminescence a suitable model for 
the functional study of TGase-dependent pro- 
cesses. 
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